Home › Funds › Vanguard Group › AVBP
Vanguard Group position in AVBP
ARRIVENT BIOPHARMA INC · Health Care
Latest position (Q4 2025)1.87M sh
Reported value held$37.61M
Portfolio Weight0.00%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 648.74K | $11.59M | New |
| Q2 2024 | 651.07K | $12.08M | Hold |
| Q3 2024 | 1.35M | $31.62M | Add |
| Q4 2024 | 1.42M | $37.76M | Add |
| Q1 2025 | 1.50M | $27.80M | Add |
| Q2 2025 | 1.48M | $32.30M | Reduce |
| Q3 2025 | 2.03M | $37.44M | Add |
| Q4 2025 | 1.87M | $37.61M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVBP
- Hillhouse Capital (HHLR Advisors) 3.93M sh · $136.50M · Q2 2026
- BlackRock Inc 3.25M sh · $112.92M · Q2 2026
- Fidelity Management & Research (FMR) 2.78M sh · $96.54M · Q2 2026
- Geode Capital Management 972.63K sh · $33.80M · Q2 2026
- D. E. Shaw & Co 872.01K sh · $30.29M · Q2 2026
- Goldman Sachs Group 853.72K sh · $29.66M · Q2 2026
- Point72 Asset Management 566.80K sh · $19.69M · Q2 2026
- Millennium Management 438.66K sh · $15.24M · Q2 2026
- UBS Group AG 438.59K sh · $15.24M · Q2 2026
- Balyasny Asset Management 395.45K sh · $13.74M · Q2 2026
- Northern Trust Corp 332.75K sh · $11.56M · Q2 2026